Dtdc Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 102 Hopmeadow St, Weatogue, CT 06089 Phone: 860-651-3521 |
Dr. David Lloyd Tolk, DC Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 102 Hopmeadow St, Weatogue, CT 06089 Phone: 860-651-3521 |
Tolk Chiropractic & Wellness Center Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 102 Hopmeadow St, Weatogue, CT 06089 Phone: 860-651-3521 Fax: 860-651-6149 |
Dr. Lloyd Andrew Tolk, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 102 Hopmeadow St, Weatogue, CT 06089 Phone: 860-651-3521 Fax: 860-651-6149 |
Matthew Chere, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 102 Hopmeadow St, Weatogue, CT 06089 Phone: 860-651-3521 Fax: 860-651-6149 |
Dr. Anthony Harry Debe, D.C. Chiropractor Medicare: Medicare Enrolled Practice Location: 381 Hopmeadow St Ste 303, Weatogue, CT 06089 Phone: 860-413-2547 |
Musculoskeletal Health Centers Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 381 Hopmeadow St Ste 303, Weatogue, CT 06089 Phone: 860-413-2547 |
News Archive
Crohn's disease is an inflammatory bowel disease and its prevalence is increasing in industrialized nations. Existing treatments are considered unsatisfactory, often requiring recurring hospitalization and surgeries.
Despite activities to identify and reduce the spread of methicillin-resistant Staphylococcus aureus (MRSA) and other health care-associated infections in hospitals and health care settings nationwide, new reports released by the Agency for Healthcare Research and Quality show that MRSA is on the rise and continues to pose an alarming threat.
SpineAlign Medical, Inc. announced today that it has enrolled its initial patient in the European Observational Registry for the VerteLift System, an observation study to further assess the ability of the VerteLift System to treat the pain and dysfunction associated with osteoporotic vertebral compression fractures (VCF), while providing clinically measurable height restoration based upon previous European experience and analysis.
Results presented today at The International Liver Congress 2015 demonstrate that hepatitis C (HCV)-infected genotype-3 (GT-3) patients, with and without cirrhosis, receiving 24 weeks of sofosbuvir (SOF) in combination with ribavirin (RBV) and peginterferon (PEG) achieved the highest sustained virologic response rates at 12 weeks (SVR12), observed in a Phase 3 study, to date.
› Verified 7 days ago